Zyla Life Sciences Business Acquisition, Pro Forma Earnings Per Share, Basic
Zyla Life Sciences reported Business Acquisition, Pro Forma Earnings Per Share, Basic of -$3.24 per share for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic · last filed 2017-03-13
- Zyla Life Sciences business acquisition, pro forma earnings per share, basic for fiscal 2014 was -$3.24.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Basic 12 month |
|---|---|
| 2014-12-31 | -$3.24 10-K · filed 2017-03-13 |